Eric P. Tamm MD, Presenter: Nothing to Disclose

1) Understand the current status of staging pancreatic cancer, the impact of cross-sectional imaging on staging, and understand the category of "borderline resectable pancreatic cancer." 2) Appreciate the impact of advances in vascular reconstruction surgery on staging and surgical planning. 3) Have a basic understanding of neoadjuvant therapy, and its impact on staging.

The evolution of approaches to pancreatic cancer therapy have had several ramifications for imaging and particularly staging. This evolution has included the development of venous and, to a lesser degree, common hepatic arterial, vascular bypass grafts, and neoadjuvant therapy. These changes led to the changes in the AJCC staging guidelines to deemphasize venous involvement, and the development of the category of borderline resectable pancreatic cancer. One of the challenges in the environment of preoperative therapy is what are the typical patterns of treatment response. These changes all emphasize the importance of detailed accurate radiology reporting, which has led to the RSNA and American Pancreatic Association templates for radiology reporting. This exhibit will review these topics, with appropriate illustrative radiologic cases.

Tamm, E, Pancreas Cancer.  Radiological Society of North America 2014 Scientific Assembly and Annual Meeting, - ,Chicago IL. http://archive.rsna.org/2014/14000549.html